Andrew C Donohue
Andrew Donohue is currently the Head of Chemistry at PolyActiva Pty Ltd leading the team responsible for the synthesis and production of their drug-monomer/polymer conjugates. He gained a BSc (Hons) and PhD in chemistry from Monash University after which he undertook post-doctoral positions at CSIRO Molecular Science and the Dyson-Perrins Laboratory at the University of Oxford. Andrew has since held positions working on small molecule inhibitors of inflammation and cancer at the Biomolecular Research Institute (BRI), The Walter and Eliza Hall Institute of Medical Research (WEHI) and Cytopia Pty. Ltd. He is a keen cricketer and cyclist.
Abstracts this author is presenting:
